top of page
Lucid

R01 (NIH/NIDDK) grant application selected for funding!

The molecular mechanisms underlying nephrotic syndrome (NS) are unknown. In this three-way collaboration between Duke University (primary), University of Miami, and University of Michigan, we will examine the role of genetic defects in RCAN1 and other genes in the calcineurin signaling pathways in the pathogenesis of NS, identify predictors of response to calcineurin inhibitors, and new therapeutic targets for NS. We are excited to bring the drug discovery technologies of the Ali lab to bear on nephrotic syndrome with world-class experts in this area!

85 views0 comments

Recent Posts

See All

New lab members power up our drug discovery operation

Colin Kelley (ex. NCATS) and Omar El-wardany (practicing neurosurgeon) have joined our team and will help us power up our drug discovery operations. Colin will lead some of our screening work while Om

Rachel won Oustanding Research Recognition Award!

Super proud of our post doc Rachel Njeim for winning Oustanding Research Recognition Award at the International Podocyte Conference 2023. Next stop, small molecule therapeutic candidate for Diabetic K

Cole got accepted into the NSF REU internship program!

Cole got accepted into the NSF sponsored summer research experience (REU) at UM! He will be working on an AI-based model for cancer diagnosis and extraction of relevant features using biomedical data.

bottom of page